Back to Search
Start Over
Gut microbiome and metabolome signatures in liver cirrhosis-related complications.
- Source :
-
Clinical and molecular hepatology [Clin Mol Hepatol] 2024 Oct; Vol. 30 (4), pp. 845-862. Date of Electronic Publication: 2024 Jul 25. - Publication Year :
- 2024
-
Abstract
- Background/aims: Shifts in the gut microbiota and metabolites are interrelated with liver cirrhosis progression and complications. However, causal relationships have not been evaluated comprehensively. Here, we identified complication-dependent gut microbiota and metabolic signatures in patients with liver cirrhosis.<br />Methods: Microbiome taxonomic profiling was performed on 194 stool samples (52 controls and 142 cirrhosis patients) via V3-V4 16S rRNA sequencing. Next, 51 samples (17 controls and 34 cirrhosis patients) were selected for fecal metabolite profiling via gas chromatography mass spectrometry and liquid chromatography coupled to time-of-flight mass spectrometry. Correlation analyses were performed targeting the gut-microbiota, metabolites, clinical parameters, and presence of complications (varices, ascites, peritonitis, encephalopathy, hepatorenal syndrome, hepatocellular carcinoma, and deceased).<br />Results: Veillonella bacteria, Ruminococcus gnavus, and Streptococcus pneumoniae are cirrhosis-related microbiotas compared with control group. Bacteroides ovatus, Clostridium symbiosum, Emergencia timonensis, Fusobacterium varium, and Hungatella&#95;uc were associated with complications in the cirrhosis group. The areas under the receiver operating characteristic curve (AUROCs) for the diagnosis of cirrhosis, encephalopathy, hepatorenal syndrome, and deceased were 0.863, 0.733, 0.71, and 0.69, respectively. The AUROCs of mixed microbial species for the diagnosis of cirrhosis and complication were 0.808 and 0.847, respectively. According to the metabolic profile, 5 increased fecal metabolites in patients with cirrhosis were biomarkers (AUROC >0.880) for the diagnosis of cirrhosis and complications. Clinical markers were significantly correlated with the gut microbiota and metabolites.<br />Conclusion: Cirrhosis-dependent gut microbiota and metabolites present unique signatures that can be used as noninvasive biomarkers for the diagnosis of cirrhosis and its complications.
- Subjects :
- Humans
Male
Female
Middle Aged
Aged
Case-Control Studies
ROC Curve
Adult
Liver Cirrhosis complications
Liver Cirrhosis metabolism
Liver Cirrhosis diagnosis
Liver Cirrhosis microbiology
Liver Cirrhosis pathology
Gastrointestinal Microbiome
Feces microbiology
Feces chemistry
Metabolome
RNA, Ribosomal, 16S genetics
Subjects
Details
- Language :
- English
- ISSN :
- 2287-285X
- Volume :
- 30
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Clinical and molecular hepatology
- Publication Type :
- Academic Journal
- Accession number :
- 39048520
- Full Text :
- https://doi.org/10.3350/cmh.2024.0349